Pancreatic Cancer Research

ResearcherThomas Jefferson UniversityActive in the last 2 years

James A. Posey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0003-2692-2062; OpenAlex author ID A5005234747, A5097668374. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 0, last author 1)
Trials
2 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2000: 1 trial · 2001: none · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers, 1 trial · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 10

  1. Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. Co-author DOI 10.1186/s13014-024-02457-y↗
  2. Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancrea… Co-author DOI 10.1136/bmjopen-2023-073839↗
  3. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis. Co-author DOI 10.1016/j.ejca.2021.01.004↗
  4. Second-line treatment for metastatic pancreatic cancer. Last author PMID 32558804↗
  5. Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Co-author DOI 10.1158/1541-7786.mcr-19-0589↗
  6. Pancreatic cancer survivors' preferences, barriers, and facilitators related to physical activity and diet interventions. Co-author DOI 10.1007/s11764-016-0544-5↗
  7. RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4. Co-author DOI 10.1016/j.molonc.2016.05.004↗
  8. Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone. Co-author DOI 10.1007/s12029-015-9702-7↗
  9. Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging. Co-author DOI 10.1007/s00261-014-0107-z↗
  10. A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally… Co-author DOI 10.1007/s00280-010-1383-0↗

Trials 2

  1. Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery Principal investigator NCT02896907↗
  2. ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas Study chair NCT00005594↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Charles J. Yeo · 4 shared papers, 2019–2024 · strength 0.58
  2. Harish Lavu · 2 shared papers, 2023–2024 · strength 0.36
  3. Atrayee Basu Mallick · 2 shared papers, 2021–2024 · strength 0.33
  4. Christopher William Schultz · 2 shared papers, 2019–2023 · strength 0.25
  5. Jonathan Robert Brody · 2 shared papers, 2019–2023 · strength 0.25
  6. John D. Christein · 5 shared papers, 2011–2016 · strength 0.23
  7. Spencer Poiset · 1 shared paper, 2024 · strength 0.18
  8. Babar Bashir · 1 shared paper, 2024 · strength 0.18
  9. Adam Christopher Mueller · 1 shared paper, 2024 · strength 0.18
  10. Daniel Lin · 1 shared paper, 2024 · strength 0.18
  11. Francesca Ponzini · 1 shared paper, 2023 · strength 0.17
  12. Theresa Pluth Yeo · 1 shared paper, 2023 · strength 0.17
  13. Avinoam Nevler · 1 shared paper, 2023 · strength 0.17
  14. Anup Kasi · 1 shared paper, 2020 · strength 0.16
  15. Ravi Kumar Paluri · 1 shared paper, 2020 · strength 0.16
  16. Aileen Deng · 1 shared paper, 2021 · strength 0.15
  17. Jordan Michael Winter · 1 shared paper, 2021 · strength 0.15
  18. Steven J. Cohen · 1 shared paper, 2021 · strength 0.15
  19. Martin J. Heslin · 3 shared papers, 2014–2016 · strength 0.14
  20. Selwyn Maurice Vickers · 3 shared papers, 2011–2016 · strength 0.13
  21. Aditi Jain · 1 shared paper, 2019 · strength 0.08
  22. Teena Dhir · 1 shared paper, 2019 · strength 0.08
  23. Alex O. Haber · 1 shared paper, 2019 · strength 0.08
  24. Talia Golan · 1 shared paper, 2019 · strength 0.08
  25. Liang Xu · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.